Results 21 to 30 of about 107,265 (203)

Clinical and genetic aspects of menopausal hormone therapy - a modern paradigm. What changed COVID-19 pandemic?

open access: yesRUDN Journal of Medicine, 2022
In the modern paradigm of public health protection, much attention is paid to the health of women in peri- and postmenopause, and a personalized approach prevails.
Irina S. Zhuravleva   +4 more
doaj   +1 more source

Plasminogen influence on the PAI-1 release by human platelets [PDF]

open access: yesThe Ukrainian Biochemical Journal
РАІ-1 (plasminogen activator inhibitor type 1), as a major physiological inhibitor of tissue plasminogen activator and urokinase, plays a key role in the regulation of fibrinolysis in vivo.
O. I. Yusova   +3 more
doaj   +1 more source

PAI‐1 and atherothrombosis [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2005
Plasminogen activator inhibitor-1 (PAI-1) is the major physiologic inhibitor of tissue-type plasminogen activator in plasma, and is elevated in a variety of clinical situations that are associated with increased risk of ischemic cardiovascular events. Recent insights into the biology of PAI-1 suggest that it is more than just an innocent bystander in ...
openaire   +2 more sources

Metformin alters signaling induced crosstalk and homeostasis in the carcinogenesis paradigm “Epistemology of the origin of cancer”

open access: yes4 open, 2019
The anti-hyperglycemic drug, Metformin, is effective in treating early stages of diabetes and has been associated with a 37% decrease in cancer incidence. While the precise mechanisms for the anti-cancer effects of Metformin remain to be elucidated, this
Brücher Björn L.D.M., Jamall Ijaz S.
doaj   +1 more source

Features of plasminogen activator inhibitor-1 synthesis by local fat depots of different localization in cardiovascular diseases

open access: yesРоссийский кардиологический журнал, 2022
Aim. To determine the features of expression and secretion of plasminogen activator inhibitor-1 (PAI-1) by subcutaneous, epicardial and perivascular adipocytes depending on the complexity of coronary artery disease (CAD).Material and methods.
E. V. Belik   +6 more
doaj   +1 more source

Recombinant PAI-1 therapy restores myoendothelial junctions and erectile function in PAI-1-deficient mice [PDF]

open access: yesAndrologia, 2014
Myoendothelial junctions are specialised projections of cell : cell contact through the internal elastic lamina between endothelial cells and vascular smooth muscle cells. These junctions allow for endothelial cells and vascular smooth muscle cells to make direct membrane apposition and are involved in cell : cell communication.
P K, Kavoussi   +9 more
openaire   +2 more sources

Evidence that heparin but not hirudin reduces PAI-1 expression in cultured human endothelial cells [PDF]

open access: yes, 1999
Heparin and other antithrombotic drugs besides their anticoagulant action could have a profibrinolytic effect. We have analyzed the effect of unfractionated heparin (UFH) and hirudin on PAI-1 gene expression in human umbilical vein endothelial cells ...
Montes, R. (Ramón)   +4 more
core   +1 more source

Multifunctionality of PAI-1 in fibrogenesis: Evidence from obstructive nephropathy in PAI-1–overexpressing mice [PDF]

open access: yesKidney International, 2005
Plasminogen activator inhibitor-1 (PAI-1) has been implicated in the pathogenesis of chronic kidney disease based on its up-regulated expression and on the beneficial effects of PAI-1 inhibition or depletion in experimental models. PAI-1 is a multifunctional protein and the mechanisms that account for its profibrotic effects have not been fully ...
Matsuo, Shunya   +8 more
openaire   +2 more sources

Dual Diverse Dynamic Reversible Actions of Ankaferd on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS

open access: yesTurkish Journal of Hematology, 2012
OBJECTIVE: Ankaferd Blood Stopper (ABS) comprises a mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum ve Urtica dioica.
Afife Karabıyık   +4 more
doaj   +1 more source

Non-invasive assessment of peritoneal membrane alterations

open access: yesBulletin de la Dialyse à Domicile, 2020
The peritoneal dialysis membrane is subject to remodelling in the course of peritoneal dialysis. In the absence of longitudinal morphological studies, this process is mainly studied indirectly by the investigation of changes in peritoneal transport.
Raymond Krediet, Alena Parikova
doaj   +1 more source

Home - About - Disclaimer - Privacy